Impaired Glucose Tolerance in People with Cystic Fibrosis
Funding for this trial has been provided in full or in part by Cystic Fibrosis Foundation Therapeutics, Inc.
Number of Participants Being Recruited:
Single / Multi-Center:
STUDY BACKGROUND INFORMATION:
This study will look at identifying the frequency of abnormal blood sugars by an oral glucose tolerance test (OGTT) screening; to look at changes in blood sugar in people with diagnosed with impaired glucose tolerance (IGT) by OGTT screening; and to look at daily blood sugar in patients with abnormal one-hour OGTT blood sugar but normal two-hour blood sugar.
8 Years - 25 Years
P. aeruginosa status:
B. cepacia status:
Other Primary Eligibility Requirements:
Note: Detailed eligibility criteria information may be available on clinicaltrials.gov. If a specific
trial listing for this trial is available, a link to the specific clinicaltrials.gov listing will be present in the "More Information" section below.
The sites listed below are currently recruiting subjects. Please note that this list generally lists either the pediatric or adult program but not both even though both programs may be recruiting subjects. Also, this list does not include sites that may be participating in the study but are not yet open for recruitment. If you are interested in this study please contact your center for more information.
Children's Hospital of Philadelphia University of Pennsylvania (Pediatric), Philadelphia, PA, 19104
Kubrak, Christina Phone: (267) 426-5135 Email: email@example.com